Alyeska Investment Group, L.P. Kiniksa Pharmaceuticals, Ltd. Transaction History

Alyeska Investment Group, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $259,750 - $378,750	-25,000 Reduced 9.49%	238,412 $2.81 Million
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $157,125 - $223,892	13,795 Added 5.53%	263,412 $3 Million
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $330,500 - $477,250	25,000 Added 11.13%	249,617 $3.48 Million
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $1.56 Million - $2.24 Million	-93,501 Reduced 29.39%	224,617 $4.16 Million
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $198,630 - $283,854	-13,421 Reduced 4.05%	318,118 $5.62 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $3.94 Million - $6.61 Million	259,062 Added 357.44%	331,539 $5.08 Million
Q2 2020 Aug 14, 2020	SELL	$15.08 - $26.0 $4.75 Million - $8.19 Million	-314,950 Reduced 81.29%	72,477 $1.85 Million
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $129,983 - $321,485	24,806 Added 6.84%	387,427 $4.28 Million
Q3 2019 Nov 14, 2019	BUY	$8.15 - $15.88 $1.22 Million - $2.38 Million	150,000 Added 70.55%	362,621 $3.09 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $1.07 Million - $1.65 Million	81,119 Added 61.69%	212,621 $0
Q1 2019 May 15, 2019	BUY	$15.93 - $26.59 $751,720 - $1.25 Million	47,189 Added 55.97%	131,502 $0
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $1.41 Million - $1.72 Million	84,313 New	84,313 $1.46 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.